Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1B | P49286 | 19/20 | 0.56 |
| ▸ | MTNR1A | P48039 | 18/20 | 0.56 |
| ▸ | NQO2 | P16083 | 2/20 | 0.50 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2881136 | 1.00 | MTNR1B (0.56) | MTNR1BMTNR1ANQO2ABCB11SIGMAR1 | |
| SCHEMBL793401 | 1.00 | MTNR1B (0.56) | MTNR1BMTNR1ANQO2ABCB11SIGMAR1 | |
| SCHEMBL14327017 | 0.81 | MTNR1A (0.42) | MTNR1BMTNR1AABCB11SIGMAR1USP2 | |
| SCHEMBL805876 | 0.81 | MTNR1A (0.41) | MTNR1BMTNR1AABCB11SIGMAR1USP2 | |
| SCHEMBL123166 | 0.80 | MTNR1B (0.54) | MTNR1BMTNR1ANQO2ABCB11SIGMAR1 | |
| SCHEMBL124498 | 0.80 | MTNR1B (0.44) | MTNR1BMTNR1ANQO2ABCB11SIGMAR1 | |
| SCHEMBL124497 | 0.80 | MTNR1B (0.44) | MTNR1BMTNR1ANQO2ABCB11SIGMAR1 | |
| SCHEMBL123165 | 0.80 | MTNR1B (0.54) | MTNR1BMTNR1ANQO2ABCB11SIGMAR1 | |
| SCHEMBL1646076 | 0.79 | MTNR1B (0.39) | MTNR1BMTNR1AABCB11SIGMAR1USP2 | |
| SCHEMBL4688545 | 0.74 | MTNR1B (0.39) | MTNR1BMTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012035303-A2 | A NOVEL PROCESS FOR SYNTHESIS OF RAMELTEON, AND KEY INTERMEDIATES FOR THE SYNTHESIS OF RAMELTEON | CIPLA LIMITED ET AL (IN) | 2012-03-22 | — | — | WO | disclosed |